Adze Biotechnology

About:

Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.

Website: https://adzebiotech.com

Description:

Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founded in 2019 and is based in Coral Gables, Florida.

Total Funding Amount:

$6.15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Coral Gables, Florida, United States

Founded Date:

2019-01-01

Founders:

Michael Barry, Sidney Hopps

Number of Employees:

1-10

Last Funding Date:

2023-03-14

IPO Status:

Private

Industries: